1.44

4.35% 0.06

After Hours: 1.44

Dogwood Therapeutics Inc (DWTX)

Overview News Price History Discussions Forecast

Dogwood Therapeutics Inc stock is traded at $1.44, with a volume of 225.01K. It is up +4.35% in the last 24 hours and down -4.00% over the past month. Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Previous Close:

$1.38

Open:

$1.42

24h Volume:

225.01K

Relative Volume:

2.30

Market Cap:

$48.43M

Revenue:

Net Income/Loss:

$-28.32M

P/E Ratio:

-0.1358

EPS:

-10.6039

Net Cash Flow:

$-15.52M

1W Performance:

-10.56%

1M Performance:

-4.00%

6M Performance:

-59.55%

1Y Performance:

-68.70%

1-Day Range:

$1.28

$1.45

1-Week Range:

$1.28

$1.64

52-Week Range:

$1.28

$9.50

Dogwood Therapeutics Inc Stock (DWTX) Company Profile

Name

Dogwood Therapeutics Inc

Sector

Healthcare (1094)

Industry

Biotechnology (615)

Phone

(866) 620-8655

Address

44 MILTON AVENUE, ALPHARETTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

DWTX's Discussions on Twitter

Compare DWTX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DWTX Dogwood Therapeutics Inc	1.44	46.41M	0	-28.32M	-15.52M	-10.60
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Dogwood Therapeutics Inc Stock (DWTX) Latest News

Jul 06, 2026

Price to sales forward of Dogwood Therapeutics, Inc. – NASDAQ:DWTX - TradingView

Jul 06, 2026

Jul 03, 2026

DWTXDogwood Therapeutics Inc Latest SEC Filings - Finviz

Jul 03, 2026

Jun 30, 2026

Dogwood Therapeutics Names OrbiMed’s Iain Dukes Chair of Scientific Advisory Board - citybiz

Jun 30, 2026

Dogwood Therapeutics appoints Iain Dukes to lead advisory board - Investing.com

Jun 30, 2026

Dogwood Therapeutics appoints Iain Dukes to lead advisory board By Investing.com - Investing.com Canada

Jun 30, 2026

Press Release: Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board - Moomoo

Jun 30, 2026

Jun 29, 2026

Dogwood Therapeutics, Inc.(NasdaqCM:DWTX) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Dogwood Therapeutics, Inc.(NasdaqCM: DWTX) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Dogwood Therapeutics, Inc.(NasdaqCM: DWTX) added to Russell 3000E Index - marketscreener.com

Jun 28, 2026

Dogwood Therapeutics, Inc.(NasdaqCM: DWTX) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

DWTX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Dogwood Therapeutics Inc Actuals & Estimates (NASDAQ:DWTX) - TradingView

Jun 26, 2026

Jun 25, 2026